Intravenous nipocalimab was administered from 14 to 35 weeks of gestation in participants with pregnancies at high risk for recurrent early-onset severe HDFN. HealthDay News — For pregnancies at high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback